Target- |
MechanismCell replacements |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hemostemix Asia, Inc.
0 Patents (Medical) associated with Hemostemix Asia, Inc.
100 Deals associated with Hemostemix Asia, Inc.
100 Translational Medicine associated with Hemostemix Asia, Inc.